Christopher Ellis

BRNS

Christopher Ellis serves as Chief Operating Officer at Barinthus Biotherapeutics plc (BRNS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.3K

Total Sells

4 trades

$309.2K

Net Position

Net Seller

$307.9K

Companies Traded

BRNS

Active Period

May 2021 – Aug 2022

5 total trades

Most Recent

Sell BRNS

Aug 24, 2022 · $259.5K

Christopher Ellis's Insider Trading at Barinthus Biotherapeutics plc (BRNS)

Buys

1 · $1.3K

Sells

4 · $309.2K

Total Shares Bought

Total Shares Sold

50,005

BRNS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Aug 24, 2022	Sell	39,626	$6.55	$259.5K
Aug 17, 2022	Sell	2,824	$4.82	$13.6K
Aug 15, 2022	Sell	7,550	$4.77	$36.0K
Jun 28, 2022	Sell	5	$6.00	$30.00
May 4, 2021	Buy	75	$17.00	$1.3K

Explore More Insider Trading Data

BRNS Insider Trading Activity

View all insider trades at Barinthus Biotherapeutics plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity